ERCC1 and colorectal carcinoma: The result showed that people who carry 3 “harmful alleles” had a higher risk of CRC than those who carrying less “harmful alleles.” Therefore, the synergistic effect of MLH3 rs108621 C allele and ERCC1 rs3212986 A allele was considered as a more powerful biomarker to predict the risk of CRC.